Literature DB >> 6747601

Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice.

D P Schnurr, Y Cao, N J Schmidt.   

Abstract

N:NIH(S) II nu/nu (athymic) and +/nu (euthymic) mice were inoculated with coxsackievirus B3 (CBV-3) and examined at various times after infection for virus titres in the heart, myocarditis and serum neutralizing antibodies. Virus was recovered from the hearts of nu/nu mice for up to 94 days post-inoculation, but was not recovered from the hearts of any +/nu mice beyond 14 days. Inflammatory cell infiltration and necrosis were present in the hearts of +/nu mice at all harvest times (7, 14, 21 and 28 days). Inflammation and necrosis did not become evident in nu/nu mice until 14 days post-inoculation, and was the present in mice from each harvest until the end of the experiment (94 days). In athymic mice, myocarditis showed a strong correlation with persistence of CBV-3 in the heart. In N:NIH(S) II mice, the presence (+/nu) or absence (nu/nu) of a thymus had a major influence on the clearance of virus from the heart and on the development of myocarditis.

Entities:  

Mesh:

Year:  1984        PMID: 6747601     DOI: 10.1099/0022-1317-65-7-1197

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Coxsackievirus B-3 selection of virus resistant Buffalo green monkey kidney cells and chromosome analysis of parental and resistant cells.

Authors:  Y Cao; K H Walen; D Schnurr
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  The role of B lymphocytes in coxsackievirus B3 infection.

Authors:  I Mena; C M Perry; S Harkins; F Rodriguez; J Gebhard; J L Whitton
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

3.  Derivation and characterization of an efficiently myocarditic reovirus variant.

Authors:  B Sherry; F J Schoen; E Wenske; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 4.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.